The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Infections as a major preventable cause of human cancer
Open accessAbstract
Abstract. Kuper H, Adami H‐O & Trichopoulos D (Harvard School of Public Health, Boston, MA, USA; Karolinska Institute, Stockholm, Sweden; University of Athens Medical School, Greece). Infections as a major preventable cause of human cancer (Internal Medicine in the 21st Century). J Intern Med 2000; 248: 171–183. Infections may be responsible for over 15% of all malignancies worldwide. Important mechanisms by which infectious agents may induce carcinogenesis include the production of chronic inflammation, the transformation of cells by insertion of oncogenes and inhibition of tumour suppressors, and the induction of immunosuppression. Common characteristics shared by infectious agents linked to malignancies are that they are persistent in the host, often highly prevalent in the host population and induce cancer after a long latency. The associations between a selection of infectious agents and malignancies are covered in detail.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many cancers arise from sites of infection, chronic irritation and inflammation.”
From Inflammation and cancer (2002) · cites this paper as [11]
In the citing paper
“Tumour cells produce various cytokines and chemokines that attract leukocytes.”
From Inflammation and cancer (2002) · cites this paper as [11]
In the citing paper
“The Gram-negative bacterium H. pylori is established as a definite carcinogen for the development of gastric cancer — the second most common type of cancer globally11,29 — and DNA damage resulting from chronic inflammation is believed the mechanism32.”
From Inflammation and cancer (2002) · cites this paper as [11]
In the citing paper
“Genetic and functional experiments indicate that neutrophils, mast cells, eosinophils and activated T lymphocytes also contribute to malignancies by releasing extracellular proteases, pro-angiogenic factors and chemokines11,23–26.”
From Inflammation and cancer (2002) · cites this paper as [11]
In the citing paper
“Indeed, there is a growing body of evidence that many malignancies are initiated by infections11,27–29 (Table 1) — upwards of 15% of malignancies worldwide can be attributed to infections, a global total of 1.2 million cases per year11.”
From Inflammation and cancer (2002) · cites this paper as [11]
In the citing paper
“Indeed, there is a growing body of evidence that many malignancies are initiated by infections11,27–29 (Table 1) — upwards of 15% of malignancies worldwide can be attributed to infections, a global total of 1.2 million cases per year11.”
From Inflammation and cancer (2002) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,766
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,804
The Environment and Disease: Association or Causation?
Hill, A. B. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800503 · Cited by 6,974
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Alter, M. J., Kruszon‐Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,973
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
Beasley, R. P., Lin, C., Hwang, L., & Chien, C. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90585-7 · Cited by 2,856
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
Adult T-cell leukemia: clinical and hematologic features of 16 cases
Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K., & Uchino, H. (1977) · Blood · doi:10.1182/blood.v50.3.481.bloodjournal503481 · Cited by 2,315
Helicobacter pylori Infection and Gastric Lymphoma
Parsonnet, J., Hansen, S., Rodríguez, L. V., Gelb, A. B., Warnke, R. A., Jellum, E., Orentreich∥, N., Vogelman∥, J. H., & FRIEDMAN, G. D. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405053301803 · Cited by 1,826
Miyoshi, I., Kubonishi, I., Yoshimoto, S., Akagi, T., Ohtsuki, Y., Shiraishi, Y., Nagata, K., & Hinuma, Y. (1981) · Nature · doi:10.1038/294770a0 · Cited by 1,402
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
Hausen, H. Z. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.690 · Cited by 1,297
Research works printed but not linked: 12
- Parsonnet J., 1999, Microbes and Malignancy., 3
- Zur Hausen H., 1999, Microbes and Malignancy., 107
- IARC, Hepatitis viruses., 1994, IARC monographs on the evaluation of carcinogenic risks to humans.
- Robinson WS., 1999, Microbes and Malignancy., 232
- Chung RT, 1999, Microbes and Malignancy., 267
- IARC, Infections with Epstein–Barr virus, human herpes viruses., 1997, IARC monographs on the evaluation of carcinogenic risks to humans., 70
- Pagona JS., 1975, Cold Spring Harbor Symposium on quantitative biology: tumor viruses, XXIX, 797
- Chang Y., 1999, Microbes and Malignancy., 207
- Newton R, 1999, Infections and Human Cancer., 237
- IARC. Schistosomes, Liver Flukes and Helicobacter Pylori., 1994, Monographs on the Evaluation of Carcinogenic Risks to Humans no. 61.
- Danesh J., 1999, Infections and Human Cancer., 263
- EkströmA‐M.Factors related to the occurence of gastrric adenocarcinoma subtypes.Doctoral Dissertation Stockholm: Karolinska Institutet 2000.
Cited by
Sorted by citations
Items 301–400 of 738
Gut microbiota and the human gut physiological changes
Bajinka, O., Darboe, A., Tan, Y., Abdelhalim, K. A., & Cham, L. B. (2020) · Annals of Microbiology · doi:10.1186/s13213-020-01608-2 · Cited by 39
PD-L1 Up-Regulation in Prostate Cancer Cells by Porphyromonas gingivalis
Groeger, S. E., Wu, F., Wagenlehner, F. R. A., Dansranjav, T., Ruf, S., Denter, F., & Meyle, J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.935806 · Cited by 37
Are oral and dental diseases linked to cancer?
Meurman, J. H., & Martínez, A. B. (2011) · Oral Diseases · doi:10.1111/j.1601-0825.2011.01837.x · Cited by 36
Exploration of lung mycobiome in the patients with non-small-cell lung cancer
Zhao, Y., Yi, J., Xiang, J., Jia, W. P., Chen, A., Chen, L., Zheng, L., Zhou, W. H., Wu, M., Yu, Z., et al. (2023) · BMC Microbiology · doi:10.1186/s12866-023-02790-4 · Cited by 36
A clinical perspective on the role of chronic inflammation in gastrointestinal cancer
Alguel, H., & Rasch, S. (2014) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s43457 · Cited by 37
Magdy, A., Elhadidy, M., Ellatif, M. E. A., Nakeeb, A. E., Abdallah, E., Thabet, W., Youssef, M., Khafagy, W., Morshed, M. M., & Farid, M. (2015) · International Journal of Surgery · doi:10.1016/j.ijsu.2015.04.077 · Cited by 35
Emerging Complexity of Protein Ubiquitination in the NF- B Pathway
Habelhah, H. (2010) · Genes & Cancer · doi:10.1177/1947601910382900 · Cited by 36
A systematic approach to cancer: evolution beyond selection
Miller, W. B., & Torday, J. S. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0131-4 · Cited by 35
Wang, D., Guo, D. L., Shi, F., Zhu, Y. J., Li, A., Kong, L., Teng, F., & Yu, J. (2019) · Future Oncology · doi:10.2217/fon-2019-0288 · Cited by 35
The Role of Inflammation and Proteinases in Tumor Progression
Herszényi, L., Lakatos, G., Hritz, I., Varga, M. Z., Cierny, G., & Tulassay, Z. (2012) · Digestive Diseases · doi:10.1159/000336914 · Cited by 35
Risk factors for esophageal cancer in a high-incidence area of Malawi
Geßner, A. L., Borkowetz, A., Wilhelm, T. J., Ludzu, E., Baier, M., Mastala, Y., Nyirenda, S., & Mothes, H. K. (2021) · Cancer Causes & Control · doi:10.1007/s10552-021-01482-6 · Cited by 34
Sørensen, H. T., Olsen, J. H., Jepsen, P., Johnsen, S. P., Schønheyder, H. C., & Mellemkjær, L. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602120 · Cited by 34
Cao, D., Jiang, J., Tsukamoto, T., Liu, R., Ma, L., Jia, Z., Kong, F., Oshima, M., & Cao, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120938 · Cited by 34
The TLR4/ERK/PD‑L1 axis may contribute to NSCLC initiation
Kang, X., Li, P., Zhang, C., Zhao, Y., Hu, H., & Wen, G. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5068 · Cited by 34
Infection and cancer: the common vein
Thomas‐Tikhonenko, A., & Hunter, C. A. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00071-0 · Cited by 34
Targeting Inflammation to Improve Tumor Drug Delivery
Gkretsi, V., Zacharia, L. C., & Stylianopoulos, T. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.07.006 · Cited by 34
The role of inflammation in HPV infection of the Oesophagus
Schäfer, G., Kabanda, S. M., van Rooyen, B., Bergant, M., Banks, L., & Parker, M. I. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-185 · Cited by 33
Impact of bacterial infection and intestinal microbiome on colorectal cancer development
Sun, J. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001979 · Cited by 35
Malignant transformation of keratocystic odontogenic tumor: Two case reports
Tan, B., Yan, T. S., Lee, S., Teck, K. C., Poon, C. Y., Goh, C. H. K., & Balakrishnan, A. (2013) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2013.01.002 · Cited by 33
Kiziltepe, T., Yan, A. C., Dong, M., Jonnalagadda, V. S., Dedon, P. C., & Engelward, B. P. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.12.011 · Cited by 34
Mammary tissue microenvironment determines T cell‐dependent breast cancer‐associated inflammation
Takahashi, K., Nagai, N., Ogura, K., Tsuneyama, K., Saiki, I., Irimura, T., & Hayakawa, Y. (2015) · Cancer Science · doi:10.1111/cas.12685 · Cited by 32
Nguyen-Dinh, S.-H., Do, A., Pham, T. N. D., Dao, D. Y., Nguy, T. N., & Chen, M. S. (2018) · World Journal of Hepatology · doi:10.4254/wjh.v10.i1.116 · Cited by 32
Dietary inflammatory index and risk of upper aerodigestive tract cancer in Japanese adults
Abe, M., Shivappa, N., Ito, H. M., Oze, I., Abe, T., Shimizu, Y., Hasegawa, Y., Kiyohara, C., Nomura, M., Ogawa, Y., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25288 · Cited by 35
The Central Role of Inflammation Associated with Checkpoint Inhibitor Treatments
Vâjâitu, C., DRAGHICI, C. C., Solomon, I., Lisievici, C. V., Popa, A. V., Lupu, M., Căruntu, C., Constantin, M. M., & Voiculescu, V. M. (2018) · Journal of Immunology Research · doi:10.1155/2018/4625472 · Cited by 32
Application of Anti-Inflammatory Agents in Prostate Cancer
Hatano, K., Fujita, K., & Nonomura, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082680 · Cited by 33
Bacelar, A., Castro, L. G. M. C., de Queiroz, A. C., & Café, E. (2007) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702007000500014 · Cited by 32
Troost, E. G. C., Hold, G. L., Smith, M. G., Chow, W., Rbkin, C. S., McColl, K. E. L., & El-Omar, E. M. (2003) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2003/397060 · Cited by 32
Lymphangiogenesis, inflammation and metastasis.
SCHOPPMANN, S. F. (2005) · PubMed · Cited by 32
Microbial deprivation, inflammation and cancer
von Hertzen, L. C., Joensuu, H., & Haahtela, T. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9284-1 · Cited by 31
Ouaguia, L., Mrizak, D., Renaud, S., Moralès, O., & Delhem, N. (2014) · Mediators of Inflammation · doi:10.1155/2014/564296 · Cited by 31
The microbiome of HPV-positive tonsil squamous cell carcinoma and neck metastasis
Rajasekaran, K., Carey, R. M., Lin, X., Seckar, T. D., Wei, Z., Chorath, K. T., Newman, J. G., O'Malley, B. W., Weinstein, G. S., Feldman, M. D., et al. (2021) · Oral Oncology · doi:10.1016/j.oraloncology.2021.105305 · Cited by 30
Das, L., & Vinayak, M. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.889824 · Cited by 30
Inflammation in Urological Malignancies: The Silent Killer
Catalano, M., Roviello, G., Santi, R., Villari, D., Spatafora, P., Galli, I. C., Sessa, F., Conte, F. L., Mini, E., Cai, T., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010866 · Cited by 31
Messeha, S. S., Zarmouh, N. O., Mendonca, P., Alwagdani, H., Kolta, M. G., & Soliman, K. F. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201116 · Cited by 29
Increased risk of incident primary cancer after Staphylococcus aureus bacteremia
Gotland, N., Hansen, M.-L. U., Sandholdt, H., Mejer, N., Lundbo, L. F., Petersen, A., Larsen, A. R., & Benfield, T. (2020) · Medicine · doi:10.1097/md.0000000000019984 · Cited by 29
Li, Y., Gao, Z., Zhang, Y., Chen, F., An, P., Wu, H., You, C., & Sun, B. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.127610 · Cited by 29
Xin, Y., Zhang, X., Li, Y., Yang, Y., Chen, Y., Wang, Y., Zhou, X., & Li, X. (2021) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-021-02965-4 · Cited by 31
Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma
Rios, R. S., Zheng, K. I., & Zheng, M.-H. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001888 · Cited by 29
Schistosomiasis and bladder cancer: similarities and differences from urothelial cancer
Zaghloul, M. S., & Gouda, I. (2012) · Expert Review of Anticancer Therapy · doi:10.1586/era.12.49 · Cited by 29
Mannan-binding lectin (MBL) in women with tumours of the reproductive system
Świerzko, A. S., Florczak, K., Cedzyński, M., Szemraj, J., Wydra, D. G., Bąk‐Romaniszyn, L., Emerich, J., & Sułowska, Z. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0250-7 · Cited by 29
van de Schans, S. A. M., van Spronsen, D. J., Hooijkaas, H., Janssen-Heijnen, M. L. G., & Coebergh, J. W. W. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.11.001 · Cited by 29
Langagergaard, V., Nørgård, B. M., Mellemkjær, L., Pedersen, L. H., Rothman, K. J., & Sørensen, H. T. (2003) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200307000-00007 · Cited by 29
Inflammation in the molecular pathogenesis of cancer and atherosclerosis
Vidal‐Vanaclocha, F. (2009) · Reumatología Clínica · doi:10.1016/j.reuma.2008.12.008 · Cited by 29
Myocyte enhancer factor 2D provides a cross-talk between chronic inflammation and lung cancer
Zhu, H., Shi, L., Zhang, Y., Zhu, Y., Bai, C., Wang, X., & Zhou, J. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1168-x · Cited by 29
The Urinary Microbiome in Health and Disease: Relevance for Bladder Cancer
Kuštrimović, N. Z., Bilato, G., Mortara, L., & Baci, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031732 · Cited by 31
Cancer risk in patients with hepatitis C virus infection: a population‐based study in Sweden
Liu, X., Chen, Y., Wang, Y., Dong, X., Wang, J., Tang, J., Sundquist, K., Sundquist, J., & Ji, J. (2017) · Cancer Medicine · doi:10.1002/cam4.988 · Cited by 28
Role of monocyte‐lineage cells in prostate cancer cell invasion and tissue factor expression
Lindholm, P. F., Lü, Y., Adley, B. P., Vladislav, I. T., Jovanovic, B. D., Sivapurapu, N., Yang, X. J., & Kajdacsy‐Balla, A. (2010) · The Prostate · doi:10.1002/pros.21202 · Cited by 28
Na, H., & Woo, J.-H. (2014) · Journal of Cancer Prevention · doi:10.15430/jcp.2014.19.4.259 · Cited by 28
Apoptotic caspase inhibits innate immune signaling by cleaving NF-κBs in both Mammals and Flies
Wu, D., Wang, Z., Zhang, J., Robinson, A. G., Lyu, B., Chen, Z., Wang, C., Wei, B., Xia, X., Zhang, Q. H., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05156-2 · Cited by 29
Rafiq, S., Huma, N., Rakariyatham, K., Hussain, I., Gulzar, N., & Hayat, I. (2017) · International Journal of Dairy Technology · doi:10.1111/1471-0307.12483 · Cited by 27
Qiao, H., Li, H., Wen, X.-H., Tan, X.-R., Yang, C., & Liu, N. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01068-22 · Cited by 28
Association Between NFKB1 -94ins/delATTG Promoter Polymorphism and Cancer Risk: A Meta-Analysis
Zou, Y., Yuan, F., Feng, X.-L., Tao, J., Ding, N., Pan, F., & Wang, F. (2010) · Cancer Investigation · doi:10.3109/07357907.2010.535054 · Cited by 27
Microbial mysteries: Staphylococcus aureus and the enigma of carcinogenesis
Odunitan, T. T., Apanisile, B. T., Akinboade, M. W., Abdulazeez, W. O., Oyaronbi, A. O., Ajayi, T. M., Oyekola, S. A., Ibrahim, N. O., Nafiu, T., Afolabi, H. O., et al. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106831 · Cited by 27
Does Honey Have the Characteristics of Natural Cancer Vaccine?
Othman, N. H. (2012) · Journal of Traditional and Complementary Medicine · doi:10.1016/s2225-4110(16)30113-4 · Cited by 26
Prognostic value of systemic ımmune ınflammation ındex in patients with laryngeal cancer
Akkaş, E. A., & Yücel, B. (2021) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-021-06798-2 · Cited by 26
Deep Learning Analysis of the Adipose Tissue and the Prediction of Prognosis in Colorectal Cancer
Lin, A., Qi, C., Li, M., Guan, R., Имянитов, Е. Н., Mitiushkina, N. V., Cheng, Q., Liu, Z., Wang, X., Lyu, Q., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.869263 · Cited by 26
Cancer Immunotherapy: The Checkpoint between Chronic Colitis and Colorectal Cancer
Ephraim, R., Feehan, J., Fraser, S., Nurgali, K., & Apostolopoulos, V. (2022) · Cancers · doi:10.3390/cancers14246131 · Cited by 26
Risk of breast cancer in women with non-lactational mastitis
Chang, C., Lin, M., & Yin, W. (2019) · Scientific Reports · doi:10.1038/s41598-019-52046-3 · Cited by 27
Immune cells as anti‐cancer therapeutic targets and tools
Johansson, M., Tan, T., de Visser, K. E., & Coussens, L. M. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21230 · Cited by 26
Association Between a Dietary Inflammatory Index and Prostate Cancer Risk in Ontario, Canada
Shivappa, N., Miao, Q., Walker, M., Hébert, J. R., & Aronson, K. J. (2017) · Nutrition and Cancer · doi:10.1080/01635581.2017.1339095 · Cited by 28
The Pasteurella multocida Toxin: A New Paradigm for the Link Between Bacterial Infection and Cancer
Lax, A. J. (2012) · Current topics in microbiology and immunology · doi:10.1007/82_2012_236 · Cited by 25
Wang, D., & DuBois, R. N. (2010) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2010.08.014 · Cited by 25
Buteyn, N. J., Santhanam, R., Merchand‐Reyes, G., Murugesan, R. A., Dettorre, G. M., Byrd, J. C., Sarkar, A., Vasu, S., Mundy-Bosse, B. L., Butchar, J. P., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900885 · Cited by 25
Mouse models of gastric tumors: Wnt activation and PGE2 induction
Oshima, H., & Oshima, M. (2010) · Pathology International · doi:10.1111/j.1440-1827.2010.02567.x · Cited by 24
Alfurayhi, R., Huang, L., & Brandt, K. (2023) · Foods · doi:10.3390/foods12061192 · Cited by 24
The Past and Future of Inflammation as a Target to Cancer Prevention
Antonucci, L., & Karin, M. (2024) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-23-0423 · Cited by 26
Liu, Y., Liu, G., Liu, Q., Tan, J., Hu, X., Wang, J., Wang, Q., & Wang, X. (2017) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12595 · Cited by 24
Saied, E. M., & El-Etreby, N. (2017) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2017.01.006 · Cited by 23
Monteleone, N. J., & Lutz, C. S. (2020) · Oncotarget · doi:10.18632/oncotarget.27614 · Cited by 23
Periodontal Disease and Tooth Loss Are Associated with Lung Cancer Risk
Chen, Y., Zhu, B., Wu, C., Lin, R., & Zhang, X. (2020) · BioMed Research International · doi:10.1155/2020/5107696 · Cited by 23
Matsuzaki, K., & Okazaki, K. (2006) · Journal of Gastroenterology · doi:10.1007/s00535-006-1795-0 · Cited by 23
Hao, H., Xu, F. L., Hao, J., He, Y., Zhou, X., Dai, H., Wu, L., & Liu, F. (2014) · Inflammation · doi:10.1007/s10753-014-0044-6 · Cited by 23
Genital and urinary tract diseases and prostate cancer risk
Pelucchi, C., Talamini, R., Negri, E., Franceschi, S., & Vecchia, C. L. (2006) · European Journal of Cancer Prevention · doi:10.1097/01.cej.0000198897.40303.d4 · Cited by 23
Bronchiectasis and the risk of cancer: a nationwide retrospective cohort study
Chung, W., Lin, C., Lin, C., & Kao, C. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12599 · Cited by 26
Infective Endocarditis and Cancer Risk
Sun, L.-M., Wu, J.-N., Lin, C., Day, J. D., Liang, J., Liou, L.-R., & Kao, C. (2016) · Medicine · doi:10.1097/md.0000000000003198 · Cited by 23
Peto, T. J., Tripura, R., Lee, S. J., Althaus, T., Dunachie, S. J., Nguon, C., Dhorda, M., Promnarate, C., Chalk, J., Imwong, M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158656 · Cited by 23
CD8+ T cells mediate the antitumor activity of frankincense and myrrh in hepatocellular carcinoma
Xu, C., Lu, X. C., Liu, W., Chen, A., Meng, G., Zhang, H., Li, B., Zhang, Y., Wu, J., & Wei, J. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1508-5 · Cited by 23
Li, K., Duan, W., Zhao, H., Wang, L., Wang, W., Zhan, Y., Sun, T., Zhang, F., Yu, B., Bai, Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49733-6 · Cited by 23
Pathways of Arachidonic Acid Peroxyl Radical Reactions and Product Formation with Guanine Radicals
Crean, C. W., Geacintov, N. E., & Shafirovich, V. (2007) · Chemical Research in Toxicology · doi:10.1021/tx700281e · Cited by 23
Association between human‐Pneumocystis infection and small‐cell lung carcinoma
de la Horra, C., VARELA, J. M., Fernández-Alonso, J., Medrano, F. J., RESPALDIZA, N., Montes-Cano, M., & Calderón, E. J. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01317.x · Cited by 23
Sharma, B., Dhiman, C., Hasan, G. M., Shamsi, A., & Hassan, M. I. (2024) · Nutrients · doi:10.3390/nu16173033 · Cited by 24
RETRACTED ARTICLE: Mouse models of intestinal inflammation and cancer
Westbrook, A. M., Szakmary, A., & Schiestl, R. H. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1747-2 · Cited by 23
RetractedHyperglycemia-Induced miR-467 Drives Tumor Inflammation and Growth in Breast Cancer
Gajeton, J., Krukovets, I., Muppala, S., Verbovetskiy, D., Zhang, J., & Stenina‐Adognravi, O. (2021) · Cancers · doi:10.3390/cancers13061346 · Cited by 22
Bazzi, W. M., Tin, A. L., Sjoberg, D. D., Bernstein, M. L., & Russo, P. (2016) · PubMed · Cited by 21
Mutoh, H., Sashikawa, M., Hayakawa, H., & Sugano, K. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01609.x · Cited by 22
Zhang, M., Pan, J.-W., Tian-rong, R., Zhu, Y.-F., Han, Y.-J., & Kühnel, W. (2003) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/s0940-9602(03)80125-5 · Cited by 22
Immune recognition and tumor protection
Dranoff, G. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00315-1 · Cited by 22
Patel, B., & Priefer, R. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120374 · Cited by 21
Hypermethylation ofTGF-β1gene promoter in gastric cancer
Wang, Y. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i33.5557 · Cited by 21
Jung, J., Lee, H., Yun, T., Lee, E., Moon, H., Joo, J., Park, W. S., Choi, M., Lee, J., Lee, J. S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20480 · Cited by 21
Bacterial Infection and Associated Cancers
Zhu, C., Wang, Y., Cai, C., & Cai, Q. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-5765-6_11 · Cited by 21
Jenkins, C. R., Hewamana, S., Gilkes, A., Neelakantan, S., Crooks, P. A., Mills, K., Pepper, C. J., & Burnett, A. K. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07392.x · Cited by 21
New Forms of Physical and Psychosocial Health Risks at Work
Houtman, I. L. D., Douwes, M., Jong, T. D., Meeuwsen, J. M., Jongen, M. J., Brekelmans, F. J. A. M., de Weegh, M. N.-O., Brouwer, D., van den Bossche, S. N. J., Zwetsloot, G. I. J. M., et al. (2008) · TNO Repository · doi:10.13140/rg.2.2.21037.79845 · Cited by 21
Antimisiaris, S. G., Kallinteri, P., & Fatouros, D. G. (2010) · Pharmaceutical Sciences Encyclopedia · doi:10.1002/9780470571224.pse352 · Cited by 21
Kang, A.-R., Cho, J., Lee, N.-G., Kwon, J., Song, J., Hwang, S., Jung, I. S., Kim, J., Um, H., Oh, S. C., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.10.057 · Cited by 20
Cui, J. T., Wang, Q., Wang, H., Wang, B., & Li, L. (2017) · Cancer Biomarkers · doi:10.3233/cbm-170409 · Cited by 20
Hepatitis B and C virus infections as possible risk factor for pancreatic adenocarcinoma
Fiorino, S., Lorenzini, S., Masetti, M., Deleonardi, G., Grondona, A. G., Silvestri, T., Chili, E., Prete, P. D., Reggiani, M. L. B., Cuppini, A., et al. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.08.008 · Cited by 19
The Microbiome’s Influence on Head and Neck Cancers
Dorobisz, K., Dorobisz, T. A., & Zatoński, T. (2023) · Current Oncology Reports · doi:10.1007/s11912-022-01352-7 · Cited by 21
Clinical Significance and Prognostic Value of Pentraxin-3 as Serologic Biomarker for Lung Cancer
Zhang, D., Ren, W., Gao, Y., Wang, N., & Wu, W. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.7.4215 · Cited by 19
Kim, E.-K., Kim, Y. S., Milner, J. A., & Wang, T. T. Y. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0419 · Cited by 19
Metadata
- Authors
- Kuper, H., Adami, H. ‐., & Trichopoulos, D.
- Affiliations
- Harvard University (US)
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 2000-09
- Volume
- 248
- Issue
- 3
- Pages
- 171-183
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W2159454395
- Cited by
- 740
- References
- 109
- Citations by year
- 2026: 3 · 2025: 14 · 2024: 23 · 2023: 44 · 2022: 29 · 2021: 39 · 2020: 36 · 2019: 42 · 2018: 32 · 2017: 41 · 2016: 35 · 2015: 37 · 2014: 32 · 2013: 44 · 2012: 30
- FWCI
- 0.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Keywords
- infection, cancer prevention, carcinogenesis, chronic inflammation, oncogenes, tumour suppressor, immunosuppression, persistent infection, tumor latency
- MeSH terms
- Animals, Clonorchiasis, Humans, Neoplasms, Primary Prevention, Schistosomiasis, Virus Diseases, Helicobacter pylori, Helicobacter Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
